CorporateMerger or Acquisition2026-05-14🇩🇪
Norton Rose Fulbright advises Profil on acquisition of US clinical research organisation
source: Profil Institut für Stoffwechselforschung GmbH -> target: Tranquil Clinical and Research Consulting Services, LLC
On 2026-05-14, Profil Institut für Stoffwechselforschung GmbH completed or announced an acquisition of US-based Tranquil Clinical and Research Consulting Services, LLC. The deal used a reverse subsidiary merger and rollover equity, and it gives Profil its first clinical research presence in the United States.
0.16Significance2.0Magnitude0.2Systemic0.2Market1Articles
Location
GermanyEuropeGermanyEurope51.166, 10.451
Story Links